Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies

Diabetes Technology and Therapeutics

Volumn 18, Issue S2, 2016, Pages S223-S233

  Laffel, Lori ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ADOLESCENT; ALGORITHM; ARTICLE; BLOOD GLUCOSE MONITORING; CHILD; CONTROLLED STUDY; DEVICE INFECTION; DEVICE SAFETY; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC ACCURACY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; PRIORITY JOURNAL; SELF MONITORING; SENSOR BREAK OFF; SKIN IRRITATION; VENOUS BLOOD; ANALYSIS; BLOOD; CALIBRATION; COMPARATIVE STUDY; DEVICES; MEASUREMENT ACCURACY; PRESCHOOL CHILD; PROCEDURES; REPRODUCIBILITY; SOFTWARE; STANDARDS;

ADOLESCENT; ALGORITHMS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CALIBRATION; CHILD; CHILD, PRESCHOOL; DATA ACCURACY; DIABETES MELLITUS; FEMALE; HUMANS; MALE; REPRODUCIBILITY OF RESULTS; SOFTWARE;

EID: 84955260944     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2015.0380     Document Type: Article

References (40)

1. Petitti DB, Klingensmith GJ, Andrews JS, Bell RA, Dabelea D, Imperatore G, Linder B, Loots B, Marcovina SM, Pihoker C, Rodriguez BL, Standiford DA, Waitzfelder B, Mayer-Davis EJ; SEARCH for Diabetes in Youth Study: Glycemic control in youth with diabetes: The SEARCH for Diabetes in Youth Study. J Pediatr 2009;155:668-672.
2. Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA; T1D Exchange Clinic Network: The T1D Exchange clinic registry. J Clin Endocrinol Metab 2012;97:4383-4389.
3. Wood JR, Miller KM, Maahs DM, Beck RW, DiMeglio LA, Libman IM, Quinn M, Tamborlane WV, Woerner SE; T1D Exchange Clinic Network: Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care 2013;36:2035-2037.
4. Miller KM, Foster NC, Beck RW, Bergenstal RM, DuBose SN, DiMeglio LA, Maahs DM, Tamborlane WV; T1D Exchange Clinic Network: Current state of type 1 diabetes treatment in the U. S. : updated data from the T1D Exchange clinic registry. Diabetes Care 2015;38:971-978.
5. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476.
6. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009;32:1378-1383.
7. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care 2010;33:17-22.
8. Battelino T, Conget I, Olsen B, Schütz-Fuhrmann I, Hommel E, Hoogma R, Schierloh U, Sulli N, Bolinder J; SWITCH Study Group: The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: A randomised controlled trial. Diabetologia 2012;55:3155-3162.
9. Diabetes Research in Children Network (DirecNet) Study Group: Continuous glucose monitoring in children with type 1 diabetes. J Pediatr 2007;151:388-393.
10. Diabetes Research in Children Network (DirecNet) Study Group: FreeStyle Navigator continuous glucose monitoring system use in children with type 1 diabetes using glarginebased multiple daily dose regimens: results of a pilot trial. Diabetes Care 2008;31:525-527.
11. Diabetes Research in Children Network (DirecNet) Study Group: Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy. Pediatr Diabetes 2009;10:91-96.
12. Chase HP, Beck RW, Xing D, Tamborlane WV, Coffey J, Fox LA, Ives B, Keady J, Kollman C, Laffel L, Ruedy KJ: Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Technol Ther 2010;12:507-515.
13. Mauras N, Beck R, Xing D, Ruedy K, BuckinghamB, Tansey M, White NH, Weinzimer SA, Tamborlane W, Kollman C; Diabetes Research in Children Network (DirecNet) Study Group: A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children (4 to <10 year olds). Diabetes Care 2012;35:204-210.
14. Tsalikian E, Fox L, Weinzimer S, Buckingham B, White NH, Beck R, Kollman C, Xing D, Ruedy K; Diabetes Research in Children Network (DirecNet) Study Group: Feasibility of prolonged continuous glucose monitoring in toddlers with type 1. Pediatr Diabetes 2012;13:294-300.
15. Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M: Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 2006;29:2730-2732.
16. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care 2009;32:1947-1953.
17. Tansey M, Laffel L, Cheng J, Beck R, Coffey J, Huang E, Kollman C, Lawrence J, Lee J, Ruedy K, Tamborlane W, Wysocki T, Xing D; JDRF CGM Study Group: Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes. Diabet Med 2011;28:1118-1122.
18. Ramchandani N, Arya S, Ten S, Bhandari S: Real-life utilization of real-time continuous glucose monitoring: The complete picture. J Diabetes Sci Technol 2011;5:860-870.
19. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Wilson DM, Xing D, Beck RW, Block J, Bode B, Fox LA, Hirsch I, Kollman C, Laffel L, Ruedy KJ, SteffesM, TamborlaneWV: Hemoglobin A1c and mean glucose in patients with type 1 diabetes: Analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Care 2011;34: 540-544.
20. Diabetes Control and Complications Trial Research Group: Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994;125: 177-188.
21. Polonsky WH, Hessler D: Perceived accuracy in continuous glucose monitoring: understanding the impact on patients. J Diabetes Sci Technol 2015;9:339-341.
22. Damiano ER, McKeon K, El-Khatib FH, Zheng H, Nathan DM, Russell SJ: A comparative effectiveness analysis of three continuous glucose monitors: The Navigator, G4 Platinum, and Enlite. J Diabetes Sci Technol 2014;8:699-708.
23. Christiansen M, Bailey T, Watkins E, Liljenquist D, Price D, Nakamura K, Boock R, Peyser T: A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system. Diabetes Technol Ther 2013;15:881-888.
24. Johnson AW, Goodwin BF: The Draize test and modifications. Curr Probl Dermatol 1985;14:31-38.
25. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
26. ClarkeWL, Cox D, Gonder-FrederickLA, CarterW, Pohl SL: Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987;10:622-628.
27. Parkes JL, Slatin SL, Pardo S, Ginsberg BH: A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care 2000;23:1143-1148.
28. Bailey TS, Chang A, Christiansen M: Clinical accuracy of a continuous glucose monitoring system with an advanced algorithm. J Diabetes Sci Technol 2015;9:209-214.
29. Russell SJ, El-Khatib FH, Sinha M, Magyar KL, McKeon K, Goergen LG, Balliro C, Hillard MA, Nathan DM, Damiano ER: Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 2014;371:313-325.
30. Kovatchev BP, Renard E, Cobelli C, Zisser HC, Keith-Hynes P, Anderson SM, Brown SA, Chernavvsky DR, Breton MD, Mize LB, Farret A, Place J, Bruttomesso D, Del Favero S, Boscari F, Galasso S, Avogaro A, Magni L, Di Palma F, Toffanin C, Messori M, Dassau E, Doyle FJ 3rd: Safety of outpatient closed-loop control: first randomized crossover trials of awearable artificial pancreas. Diabetes Care 2014;37: 1789-1796.
31. Xing D, Kollman C, Beck RW, Tamborlane WV, Laffel L, Buckingham BA, Wilson DM, Weinzimer S, Fiallo-Scharer R, Ruedy KJ; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring. Diabetes Technol Ther 2011;13:351-358.
32. Diabetes Research in Children Network (DirecNet) Study Group: Youth and parent satisfaction with clinical use of the Glucowatch G2 Biographer in the management of pediatric type 1 diabetes. Diabetes Care 2005;28:1929-1935.
33. Diabetes Research in Children Network (DirecNet) Study Group: Psychological aspects of continuous glucose monitoring in pediatric type 1 diabetes. Pediatr Diabetes 2006; 7:32-38.
34. Markowitz JT, Pratt K, Aggarwal J, Volkening LK, Laffel LM: Psychosocial correlates of continuous glucose monitoring use in youth and adults with type 1 diabetes and parents of youth. Diabetes Technol Ther 2012;14:523-526.
35. Tansey M, Weinzimer S, Beck R, Ruedy K, Cheng P, TamborlaneW, Kollman C, Mauras N, Fox L, Coffey J, WhiteNH: Extended 6-month follow-up of a randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. Diabetes Care 2013;36:e63.
36. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group: Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010;363:311-320.
37. Slover RH, Welsh JB, Criego A, Weinzimer SA, Willi SM, Wood MA, Tamborlane WV: Effectiveness of sensoraugmented pump therapy in children and adolescents with type 1 diabetes in theSTAR3 study. PediatrDiabetes 2012;13:6-11.
38. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group: Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase. Diabetes Care 2011;34:2403-2405.
39. Kaiserman K, Buckingham BA, Prakasam G, Gunville F, Slover RH, Wang Y, Nguyen X, Welsh JB: Acceptability and utility of the mySentry remote glucose monitoring system. J Diabetes Sci Technol 2013;7:356-361.
40. Dexcom. www. dexcom. com/dexcom-g4-platinum-share (accessed December 8, 2015).